Description
BLOOD AND BLOOD COMPONENTS
First action · last action
2007-10-01 · 2007-10-01
Transactions
1
First transaction's obligation
$2,691,447
Base + all options value (sum of deltas)
$2,691,447
Extent competed
—
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA256P0318
NAICS
325414 · BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2007-10-01+$2,691,447= $2,691,447
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2007-10-01 | +$2,691,447 | $2,691,447 | BLOOD AND BLOOD COMPONENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI KNHCD93LLRC3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0036 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $55,000 | FY2026 |
| 36C25625D0001 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C25625N0107 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $29,411 | FY2025 |
| 36C25620P0075 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $210,852 | FY2020 |
| VA25612J0847 | 580-HOUSTON · 6505 · DRUGS AND BIOLOGICALS | $1,907,978 | FY2012 |
| VA580C10209 | 580-HOUSTON · 6506 · BLOOD | $2,036,500 | FY2011 |
Other recipients under 6505 from 580-HOUSTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0353 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 580-HOUSTON | $5,477 | FY2013 |
| VA25613P0134 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $8,806 | FY2013 |
| VA25612P2546 | MCKESSON PLASMA AND BIOLOGICS LLC | 580-HOUSTON | $10,147 | FY2012 |
| VA25612P2560 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $9,088 | FY2012 |
| VA25612F2494 | ACTELION PHARMACEUTICALS US, INC. | 580-HOUSTON | $4,293 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_V580C85137_3600_VA256P0318_3600 · retrieved 2026-09-26.